Correction

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. (vol 9, pg 381, 2010)

LANCET NEUROLOGY (2010)

Volume 9, Issue 8, Pages 759-759

DOI: 10.1016/S1474-4422(10)70033-8

Click your name to claim this paper and add it to your profile.